These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5255886)

  • 21. Estimation of the molecular weights of the polypeptide chains from the isolated hemagglutinin and neuraminidase subunits of influenza viruses.
    Webster RG
    Virology; 1970 Mar; 40(3):643-54. PubMed ID: 5461846
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of phospholipase C on influenza viruses: limited release of "soluble" V-antigens and of neuraminidase.
    Neurath AR; Rubin BA
    Life Sci; 1967 Mar; 6(6):575-80. PubMed ID: 4291878
    [No Abstract]   [Full Text] [Related]  

  • 23. Interferon bioassay: reduction in yield of myxovirus neuraminidases.
    Sedmak JJ; Grossberg SE
    J Gen Virol; 1973 Oct; 21():1-7. PubMed ID: 4357373
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic recombination between influenza viruses Ao-NWS and A2-Hong Kong.
    Tobita K
    Arch Gesamte Virusforsch; 1971; 34(2):119-30. PubMed ID: 5170604
    [No Abstract]   [Full Text] [Related]  

  • 25. Release of neuraminidase from hemagglutinins caused by treatment of influenza viruses with ether. (Brief report).
    Neurath AR; Rubin BA; Hartzell RW
    Arch Gesamte Virusforsch; 1969; 28(3):421-3. PubMed ID: 5386786
    [No Abstract]   [Full Text] [Related]  

  • 26. Physicochemical membrane changes in Ehrlich ascites tumor cells infected with oncolytic influenza virus.
    Fresen KO; Dübendorfer A
    Arch Gesamte Virusforsch; 1973; 41(3):267-76. PubMed ID: 4737974
    [No Abstract]   [Full Text] [Related]  

  • 27. Electron microscopy of influenza virus.
    Wrigley NG
    Br Med Bull; 1979 Jan; 35(1):35-8. PubMed ID: 367484
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of antigenic and biological properties of influenza A viruses isolated different epidemics of the same cycle.
    Luzjanina TY; Golubev DB; Ivanova NA; Grinbaum EB; Zykov MP
    Ann Microbiol (Paris); 1975 Dec; 126(4):461-70. PubMed ID: 59567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of influenza virus neuraminidases: peptide changes associated with antigenic divergence between early and late N2 neuraminidases.
    Kendal AP; Kiley MP
    J Virol; 1973 Dec; 12(6):1482-90. PubMed ID: 4761727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological relationships between the neuraminidases in influenza viruses.
    Paniker CK
    J Gen Virol; 1968 May; 2(3):385-94. PubMed ID: 5675579
    [No Abstract]   [Full Text] [Related]  

  • 31. Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.
    Aymard-Henry M; Coleman MT; Dowdle WR; Laver WG; Schild GC; Webster RG
    Bull World Health Organ; 1973; 48(2):199-202. PubMed ID: 4541685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flocculation of influenza virus by specific anti-neuraminidase antibody.
    Kendal AP; Madeley CR
    Arch Gesamte Virusforsch; 1970; 31(3):219-29. PubMed ID: 4099195
    [No Abstract]   [Full Text] [Related]  

  • 33. Elicitation of antibody response against influenza viruses by different viral subunit preparations.
    Rubin BA; Pierzchala WA; Neurath AR
    Arch Gesamte Virusforsch; 1967; 20(2):268-71. PubMed ID: 5598015
    [No Abstract]   [Full Text] [Related]  

  • 34. Influenza A2 neuraminidases and their changes during persistance of viruses in tissue cultures.
    Golubev DB; Paramonova MS; Medvedeva MN; Poljakov YM
    Z Gesamte Hyg; 1975 Apr; 21(4):324-9. PubMed ID: 1224702
    [No Abstract]   [Full Text] [Related]  

  • 35. [Structure and functional role of the carbohydrate component of the influenza virus].
    Kharitonenkov IG
    Vopr Virusol; 1981; (3):262-71. PubMed ID: 7027629
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigenic relationships between the neuraminidases of influenza B virus.
    Chakraverty P
    Bull World Health Organ; 1972; 46(4):473-6. PubMed ID: 4538191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective removal of neuraminidase from influenza A 2 viruses.
    Bachmayer H; Schmidt G
    Med Microbiol Immunol; 1972; 158(2):91-4. PubMed ID: 4641943
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of nonaqueous solvents on the quaternary structure of viruses: a procedure for the simultaneous concentration, purification and disruption of influenza viruses.
    Neurath AR; Rubin BA; Sillaman J; Tint H
    Microbios; 1971 Sep; 4(14):145-50. PubMed ID: 5162006
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of some drugs and of ceruloplasmin on experimental influenza APR 8/34 (H0N1) infection in the mouse.
    Tomas E; Samuel I; Bârnaure F
    Virologie; 1979; 30(3):233-4. PubMed ID: 538885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.